FIBROSTENOTIC CROHN'S DISEASE

Clinical trials for FIBROSTENOTIC CROHN'S DISEASE explained in plain language.

Never miss a new study

Get alerted when new FIBROSTENOTIC CROHN'S DISEASE trials appear

Sign up with your email to follow new studies for FIBROSTENOTIC CROHN'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 2 Completed 1

New hope for Crohn's scarring? early safety trial completed

Knowledge-focused Completed

This study tested a new medicine called AGMB-129 in 30 healthy adults to see if it is safe and how the body processes it. The drug is being developed to treat scarring and blockages in the gut caused by Crohn's disease, for which there are no approved treatments yet. This early-p…

Matched conditions: FIBROSTENOTIC CROHN'S DISEASE

Phase: PHASE1 • Sponsor: Agomab Spain S.L.U. • Aim: Knowledge-focused

Last updated Apr 29, 2026 15:15 UTC

FIBROSTENOTIC CROHN'S DISEASE

Get alerted when new FIBROSTENOTIC CROHN'S DISEASE trials appear

New hope for Crohn's scarring? early safety trial completed